Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Sernova initiated with a Buy at H.C. Wainwright » 06:07
07/05/22
07/05
06:07
07/05/22
06:07
SEOVF

Sernova

/

+

H.C. Wainwright analyst…

H.C. Wainwright analyst Joseph Pantginis initiated coverage of Sernova with a Buy rating and C$6 price target. The analyst views the company as a "differentiated regenerative medicine play" and sees initial promise of its Cell Pouch system in Type 1 diabetes patients in driving insulin independence.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.